Data Review Committees in Clinical Trials

Ensuring patient safety through an independent non-biased panel is critical in every clinical program.   

A Data Review Committee (DRC) is an independent panel of experts who periodically meet during a study to review clinical data.  The primary purpose of  is to protect the current and future patients in the trial by reviewing safety and exposure data and making unbiased recommendations to the study sponsor based on the results.  A DRC may recommend the study continue with no modification, with modification, or stop all together due to safety concerns.  The DRC can also make recommendations based on interim efficacy results - particularly in adaptive design trials -  sample size modification or stopping criteria due to efficacy or futility.

Data Review Committee Expertise

Veristat teams develop and organize many types of independent data review committees for clinical trials with various remits.   We are experienced in and can help you manage the following types of data, safety and endpoint committees :

  • Data Monitoring Committee
  • Data Safety Monitoring Board (DSMB)
  • Independent Data Monitoring Committee (IDMC)
  • Safety Review Committee (SRC)
  • Data Review Committee (DRC)
  • Clinical Endpoint Committee (CEC) / Clinical Endpoint Adjudication

Veristat has managed over 45 DRCs in the last 5 years across numerous therapeutic indications including Cardiology, Endocrinology, Gastrointestinal Disorders, Genetic Disorders, Infectious Diseases, Neurology, Oncology and Pulmonology.

ebola-data-safety-monitoring board

 Data Review Committee Services

people_working_woman_image3_opt1200px
  • Identify thought leaders in the relevant indications and medical specialties to sit on independent committee
  • Draft Data, Safety or Endpoint Committee Charter
  • Coordinate Data, Safety or Endpoint Committee meetings
  • Facilitate communication between study sponsor and committee members
  • Provide independent data analysis of clinical trial data
  • Write meeting minutes
  • Generate patient safety reports
  • Manage safety and efficacy recommendations

Learn More with These Resources

Case Study
Rapid Launch of a Phase I COVID-19 Vaccine Trial

Learn how the Veristat team quickly mobilized to help a sponsor get their clinical trial databased designed and launched in two weeks in order to achieve ...

Case Study
Rapid Response to Ebola Outbreak

When the WHO declared the Ebola Outbreak of 2014 in Africa a Global Health Emergency, Veristat was contacted to quickly set up clinical trial sites. Learn how we ...

Case Study
Understanding and Operationalizing A Complex Adaptive ...

A clinical-stage biopharmaceutical company came to Veristat with a complex statistical methodology for running a phase II adaptive design trial with the goal of ...

Request A Proposal